2018年9月4日 · What is Bifidobacterium infantis? Bifidobacterium infantis (B. infantis) is a “friendly” strain of bacteria. It’s a type of lactic acid bacteria found in the same group as Lactobacillus....

2024年2月11日 · Bifidobacterium infantis 35624, commonly referred to as B. infantis 35624, is a strain of probiotic that is garnering attention for its potential health benefits. As you explore the world of probiotics for gut health, this particular strain stands out for its ability to modulate the gut microbiota, which can be beneficial in improving digestion ...

Bifidobacterium infantis 35624 ( B infantis 35624; Bifantis, The Procter & Gamble Company, Cincinnati, OH), is a probiotic with unique abilities to reduce intestinal inflammation.

Find patient medical information for Bifidobacterium infantis oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

The results show that B. infantis 35624-feeding significantly reduced plasma CRP and pro-inflammatory cytokine levels in both gastrointestinal and non-gastrointestinal inflammatory disorders. CRP (p < 0.001), TNF-α (p < 0.001) and IL-6 (p < 0.05), were elevated in patients with psoriasis, CFS and UC compared with healthy volunteers, (Fig. 1).

We have preliminary evidence that Bifidobacterium infantis 35624 may have utility in irritable bowel syndrome (IBS). Objectives: This study was designed to confirm the efficacy of the probiotic bacteria B. infantis 35624 in a large-scale, multicenter, clinical trial of women with IBS.

2009年3月23日 · Bifidobacterium infantis 35624, discovered in the early 1990s by microbiologists at Alimentary Health in Cork, Ireland in partnership with P&G, has been independently tested and evaluated in several clinical trials conducted with humans. This latest review provides continued clinical evidence of Bifantis efficacy in helping to manage a range of ...

Bifidobacterium infantis 35624 is a food supplement with safety and survivability studies indicating it is able to reach the gut alive and is safe for human consumption. Lynseng-Williamson, K. (2017) produced an assessment of B. infantis 35624 as a food supplement, addressing tolerability across all available clinical trials, concluding ‘ a ...

2009年12月1日 · Bifidobacterium infantis 35624 ( B infantis 35624; Bifantis, The Procter & Gamble Company, Cincinnati, OH), is a probiotic with unique abilities to reduce intestinal inflammation.

2022年5月28日 · Our study supports the selective use of orally administered B. infantis 35624 for 4 weeks among patients with uncontrolled asthma. The decrease in dysfunctional Treg cells observed with B. infantis 35624 treatment is a likely mechanism of action underlying B. infantis–mediated improvements.